Health Care & Life Sciences » Pharmaceuticals | Jacobson Pharma Corp. Ltd.

Jacobson Pharma Corp. Ltd. | Cash Flow

Fiscal year is April-March. All values HKD Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
216,948.00
136,135.00
182,997.00
221,246.00
251,223.00
Depreciation, Depletion & Amortization
43,996.00
52,945.00
69,928.00
81,981.00
112,434.00
Other Funds
9,965.00
21,460.00
17,588.00
37,394.00
360.00
Funds from Operations
156,374.00
148,735.00
218,032.00
248,164.00
316,922.00
Changes in Working Capital
19,040.00
2,856.00
14,776.00
105,273.00
103,055.00
Net Operating Cash Flow
137,334.00
145,879.00
203,256.00
142,891.00
213,867.00
Capital Expenditures
200,391.00
339,612.00
134,143.00
92,354.00
86,853.00
Sale of Fixed Assets & Businesses
90,277.00
671.00
412.00
6,609.00
2,178.00
Purchase/Sale of Investments
-
-
-
77,692.00
196,074.00
Net Investing Cash Flow
126,587.00
391,017.00
133,731.00
806,894.00
332,344.00
Cash Dividends Paid - Total
1,800.00
9,628.00
1,800.00
239,325.00
41,760.00
Issuance/Reduction of Debt, Net
31,918.00
172,195.00
29,996.00
496,174.00
456,738.00
Net Financing Cash Flow
4,249.00
184,027.00
49,384.00
940,783.00
414,618.00
Net Change in Cash
14,714.00
61,234.00
19,920.00
276,760.00
297,048.00
Free Cash Flow
63,057.00
193,733.00
69,113.00
50,537.00
127,014.00
Net Assets from Acquisitions
16,473.00
52,076.00
-
795,753.00
38,992.00
Other Sources
-
-
-
2,512.00
-
Change in Capital Stock
28,002.00
-
-
721,328.00
-
Exchange Rate Effect
282.00
123.00
221.00
20.00
907.00
Other Uses
-
-
-
5,600.00
12,603.00

About Jacobson Pharma Corp.

View Profile
Address
Unit 2313-18, 23/F
Hong Kong
Hong Kong
Employees -
Website http://www.jacobsonpharma.com
Updated 07/08/2019
Jacobson Pharma Corp. Ltd. engages in the provision of generic drugs for both public and private sectors. It operates through the following segments: Generic Drugs, Proprietary Medicines, and Wholesale and Retal. The Generic Drugs segment develops, manufactures and distributes a host of off-patent medicines for various therapeutic use.